EQL Pharma is a pharmaceutical company. Currently, the focus is on development of niche and specialised pharmaceuticals, including everything from pharma for the treatment of diabetes, enlargement of blood vessels, as well as various infections and allergies. Primarily business is found in the Nordic market. EQL Pharma was founded in 2006 and is based in Lund.

Quotes for EQL Pharma AB

Right Now

+/-
0.2
%
0,70%
Latest
28.6
High
28.6
Low
27.2
Volume
3 472
Turnover (SEK)
97 265
Market Value (MSEK)
831,2
Time (Latest trade)

Board

CEO

  • Axel Schörling

Chairperson of the Board

  • Christer Fåhraeus

Board

  • Anders Månsson
  • Christer Fåhraeus
  • Linda Neckmar
  • Per Ollermark
  • Per Svangren
  • Rajiv I. Modi

Videos

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 30,69 30,69 2022-09-29
Cadila Pharmaceuticals Ltd 30,00 30,00 2022-06-28
Avanza Pension 2,73 2,73 2022-06-28
Emanuel Eriksson 2,09 2,09 2022-09-22
Lars Fåhraeus 1,27 1,27 2022-06-28
Sten Irwe 1,25 1,25 2022-06-28
Alexander Brising 1,23 1,23 2022-06-28
Magnus Hansson 1,13 1,13 2022-06-28
Carnegie Fonder 1,12 1,12 2022-08-31
Jimmie Johnsson 1,10 1,10 2022-06-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream